These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23706536)

  • 1. Backbone cyclic helix mimetic of chemokine (C-C motif) receptor 2: a rational approach for inhibiting dimerization of G protein-coupled receptors.
    Hurevich M; Ratner-Hurevich M; Tal-Gan Y; Shalev DE; Ben-Sasson SZ; Gilon C
    Bioorg Med Chem; 2013 Jul; 21(13):3958-66. PubMed ID: 23706536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of C-reactive protein on CC chemokine receptor 2-mediated chemotaxis of monocytes.
    Meng S; Zhang L; Zhao L; Fang YR; Fujimoto T; Hirano S; Inoue H; Uchihashi K; Nishikawa Y; Wu YF
    DNA Cell Biol; 2012 Jan; 31(1):30-5. PubMed ID: 21682549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor.
    Singh R; Sobhia ME
    J Biomol Struct Dyn; 2013; 31(7):694-715. PubMed ID: 22909007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a binding element for the cytoplasmic regulator FROUNT in the membrane-proximal C-terminal region of chemokine receptors CCR2 and CCR5.
    Toda E; Terashima Y; Esaki K; Yoshinaga S; Sugihara M; Kofuku Y; Shimada I; Suwa M; Kanegasaki S; Terasawa H; Matsushima K
    Biochem J; 2014 Jan; 457(2):313-22. PubMed ID: 24128342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the binding of the membrane-proximal C-terminal region of chemokine receptor CCR2 with the cytosolic regulator FROUNT.
    Esaki K; Yoshinaga S; Tsuji T; Toda E; Terashima Y; Saitoh T; Kohda D; Kohno T; Osawa M; Ueda T; Shimada I; Matsushima K; Terasawa H
    FEBS J; 2014 Dec; 281(24):5552-66. PubMed ID: 25283965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2.
    Zweemer AJ; Bunnik J; Veenhuizen M; Miraglia F; Lenselink EB; Vilums M; de Vries H; Gibert A; Thiele S; Rosenkilde MM; IJzerman AP; Heitman LH
    Mol Pharmacol; 2014 Oct; 86(4):358-68. PubMed ID: 25024169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
    Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
    BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dimerization-inhibitory activities of cyclic peptides containing a β-hairpin loop sequence of the EGF receptor.
    Mizuguchi T; Ohara N; Iida M; Ninomiya R; Wada S; Kiso Y; Saito K; Akaji K
    Bioorg Med Chem; 2012 Oct; 20(19):5730-7. PubMed ID: 22959765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
    Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
    Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt).
    Tal-Gan Y; Hurevich M; Klein S; Ben-Shimon A; Rosenthal D; Hazan C; Shalev DE; Niv MY; Levitzki A; Gilon C
    J Med Chem; 2011 Jul; 54(14):5154-64. PubMed ID: 21650457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in CCR2 antagonists.
    Xia M; Sui Z
    Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2.
    O'Boyle G; Brain JG; Kirby JA; Ali S
    Mol Immunol; 2007 Mar; 44(8):1944-53. PubMed ID: 17081610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein promotes monocyte chemoattractant protein-1--mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes.
    Han KH; Hong KH; Park JH; Ko J; Kang DH; Choi KJ; Hong MK; Park SW; Park SJ
    Circulation; 2004 Jun; 109(21):2566-71. PubMed ID: 15136507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol reduces MCP-1-induced chemotaxis and adhesion of THP-1 monocytes by inhibiting CCR2 gene expression.
    Chuang SY; Yang SH; Pang JH
    Biochem Biophys Res Commun; 2011 Jul; 411(2):402-8. PubMed ID: 21756880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.
    Wisniewski T; Bayne E; Flanagan J; Shao Q; Wnek R; Matheravidathu S; Fischer P; Forrest MJ; Peterson L; Song X; Yang L; Demartino JA; Struthers M
    J Immunol Methods; 2010 Jan; 352(1-2):101-10. PubMed ID: 19913021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma.
    Penton-Rol G; Polentarutti N; Luini W; Borsatti A; Mancinelli R; Sica A; Sozzani S; Mantovani A
    J Immunol; 1998 Apr; 160(8):3869-73. PubMed ID: 9558092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells.
    Marra F; Romanelli RG; Giannini C; Failli P; Pastacaldi S; Arrighi MC; Pinzani M; Laffi G; Montalto P; Gentilini P
    Hepatology; 1999 Jan; 29(1):140-8. PubMed ID: 9862860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of a dimerization-arm-mimetic peptide on EGF receptor activation.
    Mizuguchi T; Uchimura H; Kakizawa T; Kimura T; Yokoyama S; Kiso Y; Saito K
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3279-82. PubMed ID: 19419869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site.
    De Paula VS; Pomin VH; Valente AP
    J Biol Chem; 2014 Aug; 289(33):22969-22979. PubMed ID: 24970887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes.
    Kuscher K; Danelon G; Paoletti S; Stefano L; Schiraldi M; Petkovic V; Locati M; Gerber BO; Uguccioni M
    Eur J Immunol; 2009 Apr; 39(4):1118-28. PubMed ID: 19291700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.